Kord Strebel, MD
Obstetrics & Gynecology · Las Vegas, NVNPI 1710956768
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.0%), speaking fees and education — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Intuitive Surgical at 49.8% of the total. Reporting peaked in 2020 at $4,793 and has fallen 79.4% since, to $989 in 2025.
Across 212 payments — averaging $50.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- AbbVie$1K
- Hologic Sales And Service, LLC$658
- Caldera Medical, Inc$471
- Astellas Pharma US Inc$414
- Boston Scientific$283
- plus $2K from 41 others
Across 1 payment — averaging $2299.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$2K
What the payments were for
- Speaking & faculty fees$5,00047%
- Food & beverage$5,57752%
- Education$941%
- Gifts$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,729 in reported general payments places this provider in the 85th percentile of 308 obstetrics & gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,320 |
| ProgesteroneProgesterone, Micronized | 35 | $1,147 |
| Fluconazole | 23 | $346 |
| Metronidazole | 18 | $153 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Las Vegas
- Darin SwainstonLas Vegas$713K
- Christina KushnirLas Vegas$502K
- Lamarr TylerLas Vegas$170K
- Ralph VennartLas Vegas$144K
- Kenneth VolkerLas Vegas$126K
- Navkaran SinghLas Vegas$104K
- Sunwook KimLas Vegas$94K
- Luis Lopez BenitezLas Vegas$89K
- Linda TranLas Vegas$72K
- Raul Romero JosephLas Vegas$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.